Working with researchers at Children’s Hospital Los Angeles and the Keck School of Medicine at the University of Southern California, the team analyzed 28 childhood tumour samples from nine cancer types archived in the BC Children’s Hospital Biobank.
They found that the pediatric cancer-focused test found more genetic mutations per sample compared with tests used to analyze adult cancers, and better identified weaknesses that can potentially be targeted with drugs.
